423 related articles for article (PubMed ID: 11598137)
1. Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells.
Wakino S; Kintscher U; Liu Z; Kim S; Yin F; Ohba M; Kuroki T; Schönthal AH; Hsueh WA; Law RE
J Biol Chem; 2001 Dec; 276(50):47650-7. PubMed ID: 11598137
[TBL] [Abstract][Full Text] [Related]
2. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.
Goetze S; Xi XP; Kawano H; Gotlibowski T; Fleck E; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 1999 May; 33(5):798-806. PubMed ID: 10226869
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells.
Goetze S; Kim S; Xi XP; Graf K; Yang DC; Fleck E; Meehan WP; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 2000 May; 35(5):749-57. PubMed ID: 10813377
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells.
Wakino S; Kintscher U; Kim S; Yin F; Hsueh WA; Law RE
J Biol Chem; 2000 Jul; 275(29):22435-41. PubMed ID: 10801895
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration.
Goetze S; Kintscher U; Kim S; Meehan WP; Kaneshiro K; Collins AR; Fleck E; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 2001 Dec; 38(6):909-21. PubMed ID: 11707695
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway.
Gouni-Berthold I; Berthold HK; Weber AA; Ko Y; Seul C; Vetter H; Sachinidis A
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):215-21. PubMed ID: 11218074
[TBL] [Abstract][Full Text] [Related]
7. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
[TBL] [Abstract][Full Text] [Related]
8. PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase.
Ghosh SS; Gehr TW; Ghosh S; Fakhry I; Sica DA; Lyall V; Schoolwerth AC
Kidney Int; 2003 Jul; 64(1):52-62. PubMed ID: 12787395
[TBL] [Abstract][Full Text] [Related]
9. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone but not rosiglitazone induces G1 cell cycle arrest and apoptosis in human and rat hepatoma cell lines.
Bae MA; Rhee H; Song BJ
Toxicol Lett; 2003 Mar; 139(1):67-75. PubMed ID: 12595159
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth.
Gouni-Berthold I; Berthold HK; Weber AA; Seul C; Vetter H; Sachinidis A
Exp Clin Endocrinol Diabetes; 2001; 109(4):203-9. PubMed ID: 11453032
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
Wakino S; Hayashi K; Kanda T; Tatematsu S; Homma K; Yoshioka K; Takamatsu I; Saruta T
Circ Res; 2004 Sep; 95(5):e45-55. PubMed ID: 15308580
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
14. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo.
Itami A; Watanabe G; Shimada Y; Hashimoto Y; Kawamura J; Kato M; Hosotani R; Imamura M
Int J Cancer; 2001 Nov; 94(3):370-6. PubMed ID: 11745416
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma activation inhibits interleukin-1beta -mediated platelet-derived growth factor-alpha receptor gene expression via CCAAT/enhancer-binding protein-delta in vascular smooth muscle cells.
Takata Y; Kitami Y; Okura T; Hiwada K
J Biol Chem; 2001 Apr; 276(16):12893-7. PubMed ID: 11278956
[TBL] [Abstract][Full Text] [Related]
16. The role of protein kinase C in activation and termination of mitogen-activated protein kinase activity in angiotensin II-stimulated rat aortic smooth-muscle cells.
Malarkey K; McLees A; Paul A; Gould GW; Plevin R
Cell Signal; 1996 Feb; 8(2):123-9. PubMed ID: 8730514
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
18. Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands.
Goetze S; Bungenstock A; Czupalla C; Eilers F; Stawowy P; Kintscher U; Spencer-Hänsch C; Graf K; Nürnberg B; Law RE; Fleck E; Gräfe M
Hypertension; 2002 Nov; 40(5):748-54. PubMed ID: 12411472
[TBL] [Abstract][Full Text] [Related]
19. Interferon regulatory factor-1 mediates PPARgamma-induced apoptosis in vascular smooth muscle cells.
Lin Y; Zhu X; McLntee FL; Xiao H; Zhang J; Fu M; Chen YE
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):257-63. PubMed ID: 14656743
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation.
de Dios ST; Bruemmer D; Dilley RJ; Ivey ME; Jennings GL; Law RE; Little PJ
Circulation; 2003 May; 107(20):2548-50. PubMed ID: 12742988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]